Orphenadrine Citrate

Product NDC
67296-0709
11-digit product format
672960709
Labeler code
67296
Product ID
67296-0709_d5fc2e9d-59d9-29cd-e053-2a95a90afa52
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
Orphenadrine Citrate
Dosage form
TABLET, EXTENDED RELEASE
Route
ORAL
Labeler
RedPharm Drug, Inc.
Application
ANDA040284
Marketing category
ANDA
Marketing start
1998-06-19
Marketing end
0000-00-00
Substance
ORPHENADRINE CITRATE
Active strength
100 mg/1
Pharmacologic classes
Centrally-mediated Muscle Relaxation [PE], Muscle Relaxant [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
67296-0709-1Orphenadrine Citrate20 in 1 BOTTLETABLET, EXTENDED RELEASE204
67296-0709-2Orphenadrine Citrate10 in 1 BOTTLETABLET, EXTENDED RELEASE104

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
67296-0709ORPHENADRINE CITRATE TABLET, EXTENDED RELEASE [REDPHARM DRUG, INC.]4Legacy NDC, 2 package rows20240712_41605713-726c-5a57-e054-00144ff88e88.zip

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYDailyMedSPL version
994521orphenadrine citrate 100 MG 12HR Extended Release Oral TabletPSN41605713-726c-5a57-e054-00144ff88e884
99452112 HR orphenadrine citrate 100 MG Extended Release Oral TabletSCD41605713-726c-5a57-e054-00144ff88e884
994521orphenadrine citrate 100 MG 12 HR Extended Release Oral TabletSY41605713-726c-5a57-e054-00144ff88e884

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionMarketing startMarketing endSampleExclude flagStatus
67296-0709-16729607090120 TABLET, EXTENDED RELEASE in 1 BOTTLE (67296-0709-1) 1998-06-190000-00-00NoNoCurrent
67296-0709-26729607090210 in 1 BOTTLEHistorical